Abnormal brain structure mediates the association between ApoE4 and slow gait among patients with pathological cognitive impairment: Results from the Ontario Neurodegenerative Research Initiative

Background Presence of at least one copy of the polymorphic apolipoprotein E ε4 allele (ApoE4) increases the risk of impairments of gait performance, particularly in elderly individuals with cognitive impairment or at risk of dementia; however, its underlying neural mechanism are unclear. This study...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Alzheimer's & dementia 2020-12, Vol.16, p.n/a
Hauptverfasser: Sakurai, Ryota, Faria‐Pieruccini, Frederico, Dilliott, Allison Ann, Hegele, Robert, Tartaglia, Carmela, McLaughlin, Paula, Binns, Malcolm, Blue, Korbin, Cornish, Ben, Sunderland, Kelly M, Beaton, Derek, Haddad, Seyyed M.H., Tan, Brian, Swartz, Richard H., Kwan, Donna, Masellis, Mario, Ramirez, Joel, Roberts, Angela C, Black, Sandra E., Symons, Sean, Strother, Stephen C, Borrie, Michael, Pasternak, Stephen H., Freedman, Morris, Bartha, Robert, Lang, Anthony, Munoz, Douglas, McIlroy, Bill, Montero‐Odasso, Manuel
Format: Artikel
Sprache:eng
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page n/a
container_issue
container_start_page
container_title Alzheimer's & dementia
container_volume 16
creator Sakurai, Ryota
Faria‐Pieruccini, Frederico
Dilliott, Allison Ann
Hegele, Robert
Tartaglia, Carmela
McLaughlin, Paula
Binns, Malcolm
Blue, Korbin
Cornish, Ben
Sunderland, Kelly M
Beaton, Derek
Haddad, Seyyed M.H.
Tan, Brian
Swartz, Richard H.
Kwan, Donna
Masellis, Mario
Ramirez, Joel
Roberts, Angela C
Black, Sandra E.
Symons, Sean
Strother, Stephen C
Borrie, Michael
Pasternak, Stephen H.
Freedman, Morris
Bartha, Robert
Lang, Anthony
Munoz, Douglas
McIlroy, Bill
Montero‐Odasso, Manuel
description Background Presence of at least one copy of the polymorphic apolipoprotein E ε4 allele (ApoE4) increases the risk of impairments of gait performance, particularly in elderly individuals with cognitive impairment or at risk of dementia; however, its underlying neural mechanism are unclear. This study examined the association among ApoE4, gait performance, and brain structural changes among elderly individuals with cognitive impairment. Method Overall, 269 older adults with Alzheimer’s disease, cerebrovascular disease with and without cognitive impairment, and mild cognitive impairment were included from the Ontario Neurodegenerative Disease Research Initiative, who were either ApoE4 carriers (n=98) or non‐ApoE4 (n=171) carriers. Gait speed was measured using an electronic walkway; speed
doi_str_mv 10.1002/alz.044540
format Article
fullrecord <record><control><sourceid>wiley</sourceid><recordid>TN_cdi_wiley_primary_10_1002_alz_044540_ALZ044540</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>ALZ044540</sourcerecordid><originalsourceid>FETCH-LOGICAL-u780-c1c88ca62623a207ef73d913b84dfd8e3cf486043e7b8a0ac0aad290bfd5ee623</originalsourceid><addsrcrecordid>eNo9UMtKw0AUDaJgrW78gvsDqTN5110oVQvFgnTlJtxMbpKRZKbMTAz6e_6YaSuu7jmX84DjefecLThjwQN23wsWRXHELrwZj-PAj4N0efmPE3bt3Vj7wVjEMh7PvJ-8VNr02EFpUCqwzgzCDYagp0qiIwuuJUBrtZio1ApKciORgvyg1xGgqsB2eoQGpQPstWrgMAlJOQujdO2RtbrTjRRTi9CNkk5-Esj-gNL0k-4R3sgO3aSvje5PfTvl0EgNrzQYXVFDigyebJOU0IgWNsec0-_Wu6qxs3T3d-fe_mm9X734293zZpVv_SHNmC-4yDKBSZAEIQYspToNqyUPyyyq6iqjUNRRlrAopLTMkKFgiFWwZGVdxUSTae7xc-woO_oqDkb2aL4Kzorj9MU0fXGevsi372cU_gKQdYBc</addsrcrecordid><sourcetype>Publisher</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>Abnormal brain structure mediates the association between ApoE4 and slow gait among patients with pathological cognitive impairment: Results from the Ontario Neurodegenerative Research Initiative</title><source>Access via Wiley Online Library</source><creator>Sakurai, Ryota ; Faria‐Pieruccini, Frederico ; Dilliott, Allison Ann ; Hegele, Robert ; Tartaglia, Carmela ; McLaughlin, Paula ; Binns, Malcolm ; Blue, Korbin ; Cornish, Ben ; Sunderland, Kelly M ; Beaton, Derek ; Haddad, Seyyed M.H. ; Tan, Brian ; Swartz, Richard H. ; Kwan, Donna ; Masellis, Mario ; Ramirez, Joel ; Roberts, Angela C ; Black, Sandra E. ; Symons, Sean ; Strother, Stephen C ; Borrie, Michael ; Pasternak, Stephen H. ; Freedman, Morris ; Bartha, Robert ; Lang, Anthony ; Munoz, Douglas ; McIlroy, Bill ; Montero‐Odasso, Manuel</creator><creatorcontrib>Sakurai, Ryota ; Faria‐Pieruccini, Frederico ; Dilliott, Allison Ann ; Hegele, Robert ; Tartaglia, Carmela ; McLaughlin, Paula ; Binns, Malcolm ; Blue, Korbin ; Cornish, Ben ; Sunderland, Kelly M ; Beaton, Derek ; Haddad, Seyyed M.H. ; Tan, Brian ; Swartz, Richard H. ; Kwan, Donna ; Masellis, Mario ; Ramirez, Joel ; Roberts, Angela C ; Black, Sandra E. ; Symons, Sean ; Strother, Stephen C ; Borrie, Michael ; Pasternak, Stephen H. ; Freedman, Morris ; Bartha, Robert ; Lang, Anthony ; Munoz, Douglas ; McIlroy, Bill ; Montero‐Odasso, Manuel</creatorcontrib><description>Background Presence of at least one copy of the polymorphic apolipoprotein E ε4 allele (ApoE4) increases the risk of impairments of gait performance, particularly in elderly individuals with cognitive impairment or at risk of dementia; however, its underlying neural mechanism are unclear. This study examined the association among ApoE4, gait performance, and brain structural changes among elderly individuals with cognitive impairment. Method Overall, 269 older adults with Alzheimer’s disease, cerebrovascular disease with and without cognitive impairment, and mild cognitive impairment were included from the Ontario Neurodegenerative Disease Research Initiative, who were either ApoE4 carriers (n=98) or non‐ApoE4 (n=171) carriers. Gait speed was measured using an electronic walkway; speed &lt;1 m/s was defined as slow gait. Participants were stratified into four groups according to the presence of at least one copy of ApoE4 and slow gait. Region of interest volumes were derived by automated segmentation using a 3.0T magnetic resonance imaging system. Result Among ApoE4 carriers, 65 (24.2%) participants had slow gait. ApoE4 carriers with slow gait showed significantly higher burden of white matter hyperintensities compared with ApoE4 carriers without slow gait. Moreover, they had significantly lower hippocampal volume and greater total sulcal cerebrospinal fluid volume compared with non‐ApoE4 carriers with slow gait. These differences remained significant despite controlling for covariates (e.g., demographic and clinical characteristics, including participant type). Conclusion Our results suggest that brain structural changes, attributable to Alzheimer’s pathology, may mediate the association between ApoE4 and slow gait among elderly individuals with pathological cognitive impairment.</description><identifier>ISSN: 1552-5260</identifier><identifier>EISSN: 1552-5279</identifier><identifier>DOI: 10.1002/alz.044540</identifier><language>eng</language><ispartof>Alzheimer's &amp; dementia, 2020-12, Vol.16, p.n/a</ispartof><rights>2020 the Alzheimer's Association</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://onlinelibrary.wiley.com/doi/pdf/10.1002%2Falz.044540$$EPDF$$P50$$Gwiley$$H</linktopdf><linktohtml>$$Uhttps://onlinelibrary.wiley.com/doi/full/10.1002%2Falz.044540$$EHTML$$P50$$Gwiley$$H</linktohtml><link.rule.ids>314,780,784,1417,27924,27925,45574,45575</link.rule.ids></links><search><creatorcontrib>Sakurai, Ryota</creatorcontrib><creatorcontrib>Faria‐Pieruccini, Frederico</creatorcontrib><creatorcontrib>Dilliott, Allison Ann</creatorcontrib><creatorcontrib>Hegele, Robert</creatorcontrib><creatorcontrib>Tartaglia, Carmela</creatorcontrib><creatorcontrib>McLaughlin, Paula</creatorcontrib><creatorcontrib>Binns, Malcolm</creatorcontrib><creatorcontrib>Blue, Korbin</creatorcontrib><creatorcontrib>Cornish, Ben</creatorcontrib><creatorcontrib>Sunderland, Kelly M</creatorcontrib><creatorcontrib>Beaton, Derek</creatorcontrib><creatorcontrib>Haddad, Seyyed M.H.</creatorcontrib><creatorcontrib>Tan, Brian</creatorcontrib><creatorcontrib>Swartz, Richard H.</creatorcontrib><creatorcontrib>Kwan, Donna</creatorcontrib><creatorcontrib>Masellis, Mario</creatorcontrib><creatorcontrib>Ramirez, Joel</creatorcontrib><creatorcontrib>Roberts, Angela C</creatorcontrib><creatorcontrib>Black, Sandra E.</creatorcontrib><creatorcontrib>Symons, Sean</creatorcontrib><creatorcontrib>Strother, Stephen C</creatorcontrib><creatorcontrib>Borrie, Michael</creatorcontrib><creatorcontrib>Pasternak, Stephen H.</creatorcontrib><creatorcontrib>Freedman, Morris</creatorcontrib><creatorcontrib>Bartha, Robert</creatorcontrib><creatorcontrib>Lang, Anthony</creatorcontrib><creatorcontrib>Munoz, Douglas</creatorcontrib><creatorcontrib>McIlroy, Bill</creatorcontrib><creatorcontrib>Montero‐Odasso, Manuel</creatorcontrib><title>Abnormal brain structure mediates the association between ApoE4 and slow gait among patients with pathological cognitive impairment: Results from the Ontario Neurodegenerative Research Initiative</title><title>Alzheimer's &amp; dementia</title><description>Background Presence of at least one copy of the polymorphic apolipoprotein E ε4 allele (ApoE4) increases the risk of impairments of gait performance, particularly in elderly individuals with cognitive impairment or at risk of dementia; however, its underlying neural mechanism are unclear. This study examined the association among ApoE4, gait performance, and brain structural changes among elderly individuals with cognitive impairment. Method Overall, 269 older adults with Alzheimer’s disease, cerebrovascular disease with and without cognitive impairment, and mild cognitive impairment were included from the Ontario Neurodegenerative Disease Research Initiative, who were either ApoE4 carriers (n=98) or non‐ApoE4 (n=171) carriers. Gait speed was measured using an electronic walkway; speed &lt;1 m/s was defined as slow gait. Participants were stratified into four groups according to the presence of at least one copy of ApoE4 and slow gait. Region of interest volumes were derived by automated segmentation using a 3.0T magnetic resonance imaging system. Result Among ApoE4 carriers, 65 (24.2%) participants had slow gait. ApoE4 carriers with slow gait showed significantly higher burden of white matter hyperintensities compared with ApoE4 carriers without slow gait. Moreover, they had significantly lower hippocampal volume and greater total sulcal cerebrospinal fluid volume compared with non‐ApoE4 carriers with slow gait. These differences remained significant despite controlling for covariates (e.g., demographic and clinical characteristics, including participant type). Conclusion Our results suggest that brain structural changes, attributable to Alzheimer’s pathology, may mediate the association between ApoE4 and slow gait among elderly individuals with pathological cognitive impairment.</description><issn>1552-5260</issn><issn>1552-5279</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2020</creationdate><recordtype>article</recordtype><sourceid/><recordid>eNo9UMtKw0AUDaJgrW78gvsDqTN5110oVQvFgnTlJtxMbpKRZKbMTAz6e_6YaSuu7jmX84DjefecLThjwQN23wsWRXHELrwZj-PAj4N0efmPE3bt3Vj7wVjEMh7PvJ-8VNr02EFpUCqwzgzCDYagp0qiIwuuJUBrtZio1ApKciORgvyg1xGgqsB2eoQGpQPstWrgMAlJOQujdO2RtbrTjRRTi9CNkk5-Esj-gNL0k-4R3sgO3aSvje5PfTvl0EgNrzQYXVFDigyebJOU0IgWNsec0-_Wu6qxs3T3d-fe_mm9X734293zZpVv_SHNmC-4yDKBSZAEIQYspToNqyUPyyyq6iqjUNRRlrAopLTMkKFgiFWwZGVdxUSTae7xc-woO_oqDkb2aL4Kzorj9MU0fXGevsi372cU_gKQdYBc</recordid><startdate>202012</startdate><enddate>202012</enddate><creator>Sakurai, Ryota</creator><creator>Faria‐Pieruccini, Frederico</creator><creator>Dilliott, Allison Ann</creator><creator>Hegele, Robert</creator><creator>Tartaglia, Carmela</creator><creator>McLaughlin, Paula</creator><creator>Binns, Malcolm</creator><creator>Blue, Korbin</creator><creator>Cornish, Ben</creator><creator>Sunderland, Kelly M</creator><creator>Beaton, Derek</creator><creator>Haddad, Seyyed M.H.</creator><creator>Tan, Brian</creator><creator>Swartz, Richard H.</creator><creator>Kwan, Donna</creator><creator>Masellis, Mario</creator><creator>Ramirez, Joel</creator><creator>Roberts, Angela C</creator><creator>Black, Sandra E.</creator><creator>Symons, Sean</creator><creator>Strother, Stephen C</creator><creator>Borrie, Michael</creator><creator>Pasternak, Stephen H.</creator><creator>Freedman, Morris</creator><creator>Bartha, Robert</creator><creator>Lang, Anthony</creator><creator>Munoz, Douglas</creator><creator>McIlroy, Bill</creator><creator>Montero‐Odasso, Manuel</creator><scope/></search><sort><creationdate>202012</creationdate><title>Abnormal brain structure mediates the association between ApoE4 and slow gait among patients with pathological cognitive impairment: Results from the Ontario Neurodegenerative Research Initiative</title><author>Sakurai, Ryota ; Faria‐Pieruccini, Frederico ; Dilliott, Allison Ann ; Hegele, Robert ; Tartaglia, Carmela ; McLaughlin, Paula ; Binns, Malcolm ; Blue, Korbin ; Cornish, Ben ; Sunderland, Kelly M ; Beaton, Derek ; Haddad, Seyyed M.H. ; Tan, Brian ; Swartz, Richard H. ; Kwan, Donna ; Masellis, Mario ; Ramirez, Joel ; Roberts, Angela C ; Black, Sandra E. ; Symons, Sean ; Strother, Stephen C ; Borrie, Michael ; Pasternak, Stephen H. ; Freedman, Morris ; Bartha, Robert ; Lang, Anthony ; Munoz, Douglas ; McIlroy, Bill ; Montero‐Odasso, Manuel</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-u780-c1c88ca62623a207ef73d913b84dfd8e3cf486043e7b8a0ac0aad290bfd5ee623</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2020</creationdate><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Sakurai, Ryota</creatorcontrib><creatorcontrib>Faria‐Pieruccini, Frederico</creatorcontrib><creatorcontrib>Dilliott, Allison Ann</creatorcontrib><creatorcontrib>Hegele, Robert</creatorcontrib><creatorcontrib>Tartaglia, Carmela</creatorcontrib><creatorcontrib>McLaughlin, Paula</creatorcontrib><creatorcontrib>Binns, Malcolm</creatorcontrib><creatorcontrib>Blue, Korbin</creatorcontrib><creatorcontrib>Cornish, Ben</creatorcontrib><creatorcontrib>Sunderland, Kelly M</creatorcontrib><creatorcontrib>Beaton, Derek</creatorcontrib><creatorcontrib>Haddad, Seyyed M.H.</creatorcontrib><creatorcontrib>Tan, Brian</creatorcontrib><creatorcontrib>Swartz, Richard H.</creatorcontrib><creatorcontrib>Kwan, Donna</creatorcontrib><creatorcontrib>Masellis, Mario</creatorcontrib><creatorcontrib>Ramirez, Joel</creatorcontrib><creatorcontrib>Roberts, Angela C</creatorcontrib><creatorcontrib>Black, Sandra E.</creatorcontrib><creatorcontrib>Symons, Sean</creatorcontrib><creatorcontrib>Strother, Stephen C</creatorcontrib><creatorcontrib>Borrie, Michael</creatorcontrib><creatorcontrib>Pasternak, Stephen H.</creatorcontrib><creatorcontrib>Freedman, Morris</creatorcontrib><creatorcontrib>Bartha, Robert</creatorcontrib><creatorcontrib>Lang, Anthony</creatorcontrib><creatorcontrib>Munoz, Douglas</creatorcontrib><creatorcontrib>McIlroy, Bill</creatorcontrib><creatorcontrib>Montero‐Odasso, Manuel</creatorcontrib><jtitle>Alzheimer's &amp; dementia</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Sakurai, Ryota</au><au>Faria‐Pieruccini, Frederico</au><au>Dilliott, Allison Ann</au><au>Hegele, Robert</au><au>Tartaglia, Carmela</au><au>McLaughlin, Paula</au><au>Binns, Malcolm</au><au>Blue, Korbin</au><au>Cornish, Ben</au><au>Sunderland, Kelly M</au><au>Beaton, Derek</au><au>Haddad, Seyyed M.H.</au><au>Tan, Brian</au><au>Swartz, Richard H.</au><au>Kwan, Donna</au><au>Masellis, Mario</au><au>Ramirez, Joel</au><au>Roberts, Angela C</au><au>Black, Sandra E.</au><au>Symons, Sean</au><au>Strother, Stephen C</au><au>Borrie, Michael</au><au>Pasternak, Stephen H.</au><au>Freedman, Morris</au><au>Bartha, Robert</au><au>Lang, Anthony</au><au>Munoz, Douglas</au><au>McIlroy, Bill</au><au>Montero‐Odasso, Manuel</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Abnormal brain structure mediates the association between ApoE4 and slow gait among patients with pathological cognitive impairment: Results from the Ontario Neurodegenerative Research Initiative</atitle><jtitle>Alzheimer's &amp; dementia</jtitle><date>2020-12</date><risdate>2020</risdate><volume>16</volume><epage>n/a</epage><issn>1552-5260</issn><eissn>1552-5279</eissn><abstract>Background Presence of at least one copy of the polymorphic apolipoprotein E ε4 allele (ApoE4) increases the risk of impairments of gait performance, particularly in elderly individuals with cognitive impairment or at risk of dementia; however, its underlying neural mechanism are unclear. This study examined the association among ApoE4, gait performance, and brain structural changes among elderly individuals with cognitive impairment. Method Overall, 269 older adults with Alzheimer’s disease, cerebrovascular disease with and without cognitive impairment, and mild cognitive impairment were included from the Ontario Neurodegenerative Disease Research Initiative, who were either ApoE4 carriers (n=98) or non‐ApoE4 (n=171) carriers. Gait speed was measured using an electronic walkway; speed &lt;1 m/s was defined as slow gait. Participants were stratified into four groups according to the presence of at least one copy of ApoE4 and slow gait. Region of interest volumes were derived by automated segmentation using a 3.0T magnetic resonance imaging system. Result Among ApoE4 carriers, 65 (24.2%) participants had slow gait. ApoE4 carriers with slow gait showed significantly higher burden of white matter hyperintensities compared with ApoE4 carriers without slow gait. Moreover, they had significantly lower hippocampal volume and greater total sulcal cerebrospinal fluid volume compared with non‐ApoE4 carriers with slow gait. These differences remained significant despite controlling for covariates (e.g., demographic and clinical characteristics, including participant type). Conclusion Our results suggest that brain structural changes, attributable to Alzheimer’s pathology, may mediate the association between ApoE4 and slow gait among elderly individuals with pathological cognitive impairment.</abstract><doi>10.1002/alz.044540</doi><tpages>1</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 1552-5260
ispartof Alzheimer's & dementia, 2020-12, Vol.16, p.n/a
issn 1552-5260
1552-5279
language eng
recordid cdi_wiley_primary_10_1002_alz_044540_ALZ044540
source Access via Wiley Online Library
title Abnormal brain structure mediates the association between ApoE4 and slow gait among patients with pathological cognitive impairment: Results from the Ontario Neurodegenerative Research Initiative
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-19T02%3A18%3A17IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-wiley&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Abnormal%20brain%20structure%20mediates%20the%20association%20between%20ApoE4%20and%20slow%20gait%20among%20patients%20with%20pathological%20cognitive%20impairment:%20Results%20from%20the%20Ontario%20Neurodegenerative%20Research%20Initiative&rft.jtitle=Alzheimer's%20&%20dementia&rft.au=Sakurai,%20Ryota&rft.date=2020-12&rft.volume=16&rft.epage=n/a&rft.issn=1552-5260&rft.eissn=1552-5279&rft_id=info:doi/10.1002/alz.044540&rft_dat=%3Cwiley%3EALZ044540%3C/wiley%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true